¥5.05 ($0.75)

+0.09 (+1.81%)

SHH · Healthcare · Medical - Distribution · Tech Score Neutral · Power 52 · ¥25.5B mcap · 2.13B float · 1.66% daily turnover

Revenue

$151.8B +1.1% ▲

5Y CAGR: +8.8%

Gross Profit

$11.7B -2.2% ▼

5Y CAGR: +6.2%

Operating Income

$3.6B +20.3% ▲

5Y CAGR: +9.6%

Net Income

$2.5B +15.3% ▲

5Y CAGR: +7.7%

EPS (Diluted)

$0.50 +16.3% ▲

5Y CAGR: +10.0%

EBITDA

$4.6B -2.5% ▼

5Y CAGR: +4.4%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$110.9B	$122.4B	$140.4B	$150.1B	$151.8B
YoY Growth	+11.4%	+10.4%	+14.7%	+6.9%	+1.1%
Cost of Revenue	$101.0B	$112.6B	$129.6B	$138.1B	$140.1B
Gross Profit	$9.9B	$9.8B	$10.9B	$12.0B	$11.7B
Gross Margin	8.9%	8.0%	7.7%	8.0%	7.7%
R&D Expenses	$127M	$195M	$178M	$197M	$147M
SG&A Expenses	$5.5B	$6.0B	$6.6B	$7.1B	$7.1B
Operating Expenses	$5.5B	$6.2B	$8.0B	$9.0B	$8.1B
Operating Income	$4.4B	$3.6B	$2.9B	$3.0B	$3.6B
Operating Margin	3.9%	2.9%	2.0%	2.0%	2.4%
Interest Expense	$1.1B	$1.2B	$1.3B	$1.3B	$1.3B
Income Before Tax	$4.3B	$3.4B	$2.8B	$3.0B	$3.6B
Tax Expense	$949M	$755M	$553M	$701M	$851M
Net Income	$3.1B	$2.4B	$2.1B	$2.2B	$2.5B
Net Margin	2.8%	2.0%	1.5%	1.4%	1.7%
EPS (Diluted)	$0.58	$0.47	$0.40	$0.43	$0.50
EBITDA	$4.2B	$3.6B	$4.4B	$4.7B	$4.6B
Shares Outstanding	5.34B	5.19B	5.27B	5.06B	5.01B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$36.3B	$38.4B	$42.0B	$39.1B	$38.2B	$42.1B	$44.8B	$42.5B
Cost of Revenue	$33.3B	$35.7B	$38.9B	$36.1B	$35.1B	$38.8B	$41.4B	$39.2B
Gross Profit	$3.0B	$2.7B	$3.1B	$3.0B	$3.1B	$3.3B	$3.3B	$3.3B
Gross Margin	8.2%	7.0%	7.3%	7.6%	8.2%	7.8%	7.5%	7.7%
R&D Expenses	$31M	$49M	$36M	$31M	$31M	$31M	$24M	$33M
SG&A Expenses	$1.9B	$1.8B	$1.9B	$1.9B	$2.1B	-$2.7B	$2.1B	$2.1B
Operating Expenses	$2.3B	$1.4B	$1.8B	$2.2B	$2.2B	$2.7B	$2.6B	$2.3B
Operating Income	$631M	$1.3B	$1.3B	$712M	$908M	$593M	$774M	$983M
Operating Margin	1.7%	3.5%	3.0%	1.8%	2.4%	1.4%	1.7%	2.3%
Interest Expense	$329M	$306M	$249M	$256M	$246M	-$751M	$319M	$279M
Income Before Tax	$629M	$1.4B	$1.3B	$717M	$707M	$591M	$762M	$811M
Tax Expense	$109M	$337M	$261M	$212M	$148M	$259M	$167M	$213M
Net Income	$489M	$811M	$970M	$476M	$530M	$279M	$733M	$467M
Net Margin	1.3%	2.1%	2.3%	1.2%	1.4%	0.7%	1.6%	1.1%
EPS (Diluted)	$0.09	$0.16	$0.19	$0.10	$0.11	$0.06	$0.14	$0.09
EBITDA	$1.1B	$932M	$1.1B	$969M	$919M	$1.1B	$1.1B	$1.3B
Shares Outstanding	5.31B	5.09B	5.10B	4.86B	5.04B	5.12B	5.24B	5.04B

600998.SS SHH